Skip to main contentSkip to navigationSkip to search
Interim Report | Financials | 12 Aug, 2020 | 11:15 | Regulatory

Interim Report January-June 2020

The second quarter:

  • Order intake was MSEK 1,655 (2,201), a decline of -24.8% adjusted to -24.0% for currency effects of MSEK -18
  • Net sales were MSEK 1,726 (2,055), a decline of -16.0% adjusted to -15.5% for currency effects of MSEK -11
  • Operating profit was MSEK 153.6 (174.8), a decrease of 12.1% with an operating margin of 8.9 (8.5)%
  • Earnings after tax were MSEK 98.8 (114.5)
  • Earnings per share were SEK 0.55 (0.74)
  • Cash flow from operating activities was MSEK 230.2 (146.0)

Comments from CEO Bodil Sonesson:

  • Whilst continuing to successfully manage the Covid-19 challenges the group has delivered a respectable operating result in the quarter.
  • My sincere thanks and gratefulness go to every Group colleague. It has been a challenging episode but with great collaboration, hard work and a supportive company culture the second quarter exceeded expectations.
  • I am happy to announce our second competence centre for our Organic Response technology, this will be based in Linköping, Sweden and opened beginning of August.
  • At 1,685 MSEK, we started the second quarter with a healthy order backlog. I expect the lower second quarter order intake will be a challenge for net sales for the remainder of the year. The reducing cost base will support the operational result.
  • We have a strong balance sheet and a healthy liquidity situation. We continue to increase our focus on cash generating activities as we do not know for how long the conditions will remain.
  • We continue our strategic work with the new business area structure and we have identified many significant growth opportunities.
  • The Group is well prepared for the future and is in a healthy condition. We will emerge strategically stronger from the current situation.